SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-097840
Filing Date
2024-11-14
Accepted
2024-11-14 08:30:56
Documents
85
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0216049-10q_abvcbio.htm   iXBRL 10-Q 1380765
2 CERTIFICATION ea021604901ex31-1_abvcbio.htm EX-31.1 8245
3 CERTIFICATION ea021604901ex31-2_abvcbio.htm EX-31.2 8151
4 CERTIFICATION ea021604901ex32-1_abvcbio.htm EX-32.1 4344
5 CERTIFICATION ea021604901ex32-2_abvcbio.htm EX-32.2 4101
  Complete submission text file 0001213900-24-097840.txt   8056720

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20240930.xsd EX-101.SCH 77885
7 XBRL CALCULATION FILE abvc-20240930_cal.xml EX-101.CAL 49515
8 XBRL DEFINITION FILE abvc-20240930_def.xml EX-101.DEF 392491
9 XBRL LABEL FILE abvc-20240930_lab.xml EX-101.LAB 685730
10 XBRL PRESENTATION FILE abvc-20240930_pre.xml EX-101.PRE 404660
88 EXTRACTED XBRL INSTANCE DOCUMENT ea0216049-10q_abvcbio_htm.xml XML 898606
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 241457389
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)